^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    murine CD19 CAR-T cell therapy

    i
    Other names: murine CD19 CAR-T cell therapy, murine CD19 CAR-T cells, murine CD19 CAR-T cells therapy
    Associations

    News

    Trials
    Company:
    Shanghai Yake Biotech
    Drug class:
    CD19-targeted CAR-T immunotherapy
    Related drugs:
    Associations

    News

    Trials
    4years
    A Study of Murine CD19 CAR-T Therapy for Patients With Relapsed or Refractory CD19+ B-cell Hematological Malignancies (clinicaltrials.gov)
    P1, N=120, Recruiting, Zhejiang University
    New P1 trial • Preclinical • CAR T-Cell Therapy
    |
    CD19 (CD19 Molecule)
    |
    murine CD19 CAR-T cell therapy